SARAH MORGAN: Open Payments
NPI 1316950058 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 33 payments from 6 companies in 2025. Trend: 2023 $611 · 2024 $726 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $399 |
| Alkermes, Inc. | 6 | $202 |
| Axsome Therapeutics, Inc. | 3 | $146 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| ABBVIE INC. | 1 | $20 |
Products named: CAPLYTA, Auvelity, LYBALVI, INGREZZA, ARISTADA, TRINTELLIX, VRAYLAR.
Industry payments across CA — which companies pay providers there.
